financetom
VCTR
financetom
/
Financials
/
VCTR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Victory Capital Holdings, Inc.VCTR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
3.48B
Revenue (ttm)
893.48M
Net Income (ttm)
288.86M
Shares Out
63.66M
EPS (ttm)
4.38
PE Ratio
12.51
Forward PE
9.11
Dividend
$1.69 (3.08%)
Ex-Dividend Date
Feb 18, 2025
Volume
115,378
Open
53.48
Previous Close
54.06
Day's Range
52.65 - 54.80
52-Week Range
42.10 - 73.42
Beta
0.88
Analysts
Buy
Price Target
71.44 (+30.75%)
Earnings Date
May 8, 2025
Description >

Victory Capital Holdings, Inc., together with its subsidiaries, operates as an asset management company in the United States and internationally.

It offers investment advisory, fund administration, fund compliance, fund transfer agent, fund distribution, and other management services.

The company provides specialized investment strategies to institutions, intermediaries, retirement platforms, and individual investors.

Its investment products include actively and passively managed mutual funds; rules-based and active exchange traded funds; institutional separate accounts; variable insurance products; environmental, social, and governance, as well as impact investment strategies; alternative investments; and private closed-end funds.

Victory Capital Holdings, Inc. was incorporated in 2013 and is based in San Antonio, Texas.

Latest News >
Sagimet Biosciences Says Potential Fatty Liver Disease Drug Meets Endpoints in Phase 2B Trial
Sagimet Biosciences Says Potential Fatty Liver Disease Drug Meets Endpoints in Phase 2B Trial
Jun 6, 2024
08:39 AM EDT, 06/06/2024 (MT Newswires) -- Sagimet Biosciences ( SGMT ) said Thursday that additional data from a phase 2b trial of denifanstat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis, or MASH, showed that the study met the primary and secondary endpoints. Denifanstat, an oral daily pill, achieved statistically significant results on primary and secondary liver biopsy endpoints in...
Vista Outdoor Surges As MNC Capital Ups The Ante With Sweetened Bid: Details
Vista Outdoor Surges As MNC Capital Ups The Ante With Sweetened Bid: Details
Jun 6, 2024
Vista Outdoor Inc. ( VSTO ) shares are trading higher after MNC Capital increased its offer to acquire the company for over $3.0 billion. The revised proposal of $39.50 represents a 46% premium to the VWAP from the announcement of Vista’s transaction with the Czechoslovak Group a.s. on October 16, 2023, up to the last closing price before MNC’s initial...
Dolby Labs to acquire GE Licensing in $429 million deal
Dolby Labs to acquire GE Licensing in $429 million deal
Jun 6, 2024
June 6 (Reuters) - Dolby Laboratories ( DLB ) said on Thursday it would acquire GE Licensing, an intellectual property licensing business primarily targeting the consumer digital media and electronics sectors, in a $429 million deal. ...
Monster Beverage Reports Preliminary Results of Common Shares Tender Offer
Monster Beverage Reports Preliminary Results of Common Shares Tender Offer
Jun 6, 2024
08:39 AM EDT, 06/06/2024 (MT Newswires) -- Monster Beverage ( MNST ) said Thursday a total of about 77.4 million of its common shares were validly tendered and not validly withdrawn at $53 apiece under its modified Dutch auction tender offer. Additionally, under notice of guaranteed delivery, roughly 41.6 million of the company's shares were tendered, Monster Beverage ( MNST...
Copyright 2023-2025 - www.financetom.com All Rights Reserved